Skip to content
MarketDeck StockProof

Compare

Comparable-company multiples

Compare 2–8 tracked companies on the same stored snapshot metrics.

No ranking, recommendation or winner scoring.

Selected companies · 8 / 8

Clear all
ACUTAAS.NS ×
AJANTPHARM.NS ×
ALKEM.NS ×
ANTHEM.NS ×
APOLLOHOSP.NS ×
ASTERDM.NS ×
AUROPHARMA.NS ×
BIOCON.NS ×

Maximum 8 companies selected. Remove one to add another.

Current comparison

Comparable-company multiples

Sorting changes row order only — it is not a ranking.

Comparable-company multiples for the selected companies
ACUTAAS.NS Acutaas Chemicals Ltd. Period ending 31 Mar 2026 · Fetched 23 Sep 2026 ₹26,310.95 Cr. 73.85 15.91 50.04 21.54% 28.93% 0.02 0.05%
AJANTPHARM.NS Ajanta Pharmaceuticals Ltd. Period ending 31 Mar 2026 · Fetched 23 Sep 2026 ₹44,114.43 Cr. 41.78 9.74 28.22 23.33% 29.41% 0.05 0.79%
ALKEM.NS Alkem Laboratories Ltd. Period ending 31 Mar 2026 · Fetched 23 Sep 2026 ₹63,738.08 Cr. 27.69 4.61 18.14 16.66% 20.76% 0.12 0.96%
ANTHEM.NS Anthem Biosciences Ltd. Period ending 31 Mar 2026 · Fetched 23 Sep 2026 ₹50,088.13 Cr. 84.64 16.46 50.39 19.45% 27.65% 0.02 0.00%
APOLLOHOSP.NS Apollo Hospitals Enterprise Ltd. Period ending 31 Mar 2026 · Fetched 23 Sep 2026 ₹1,27,054.49 Cr. 65.43 13.40 33.30 20.48% 20.38% 0.60 0.23%
ASTERDM.NS Aster DM Quality Care Ltd. Period ending 31 Mar 2026 · Fetched 23 Sep 2026 ₹38,896.02 Cr. 100.21 8.50 38.35 8.48% 14.45% 0.15 0.14%
AUROPHARMA.NS Aurobindo Pharma Ltd. Period ending 31 Mar 2026 · Fetched 23 Sep 2026 ₹98,736.00 Cr. 28.17 2.61 13.52 9.25% 12.20% 0.20 0.24%
BIOCON.NS Biocon Ltd. Period ending 31 Mar 2026 · Fetched 23 Sep 2026 ₹63,219.00 Cr. 163.95 1.86 19.91 1.13% 3.77% 0.44 0.14%
Median₹56,653.56 Cr.69.649.1230.7618.05%20.57%0.140.19%
Mean₹64,019.64 Cr.73.229.1431.4915.04%19.69%0.200.32%

Median / Mean use available values only. N/A is excluded. Real zero remains zero.

Metric notes

Dividend Yield This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace

Verify the underlying methodology and evidence

Open the same ratio methodology and filing evidence on each company page.